27-Feb-2020 | Facts and Factors
Findings from Facts and Factors report “Acute Kidney Injury Treatment Market by Injury Type (Pre-renal, Intrinsic renal and Post-renal), Therapy (Intermittent hemodialysis, Continuous renal replacement therapy, and Sustained low-efficiency dialysis) and Distribution Channel (Hospital Pharmacies, Online Pharmacies, and Others): Global Industry Outlook, Market Size, Business Intelligence, Consumer Preferences, Statistical Surveys, Comprehensive Analysis, Historical Developments, Current Trends, and Forecasts, 2020–2026” states that the global Acute Kidney Injury Treatment market in 2019 was approximately USD 1349.39 million. The market is expected to grow at a CAGR of 7.33% and is anticipated to reach around USD 2204.33 million by 2026.
Acute kidney injury involves serious swelling and trauma to the abdomen. Acute kidney failure results in the sudden loss of function in the kidneys and adjustments in the state of waste products, electrolytes, and weight. Acute kidney failure is essentially a medical emergency that is fraught with severe adverse consequences. This is a condition with many different causes caused by a rapid loss of renal function culminating in the failure to maintain quantity, nutrients, electrolytes, and acid-base equilibrium. Acute kidney damage is a common condition linked with elevated mortality. Detection of the acute kidney injury based on the serum creatinine level, and urinary production assessment. Acute kidney injury arises in many different specialties in medicine and surgery, with the aged particularly vulnerable. The common cause of acute kidney failure is an infectious blood infection, and other triggers involve heart surgery, poisonous medications, or contaminants and injuries of surgical contrast. Acute retinal injury in the body lowers rates of alkaline phosphatase.
Browse the full “Acute Kidney Injury Treatment Market by Component (Scheduling, Patient Communication, Invoice/Billing, Payment Processing, Insurance Management, Dental Charting), By Deployment (On-premise, Web-based, Cloud-based): Global Industry Outlook, Market Size, Business Intelligence, Consumer Preferences, Statistical Surveys, Comprehensive Analysis, Historical Developments, Current Trends, and Forecasts, 2020–2026" report at https://www.fnfresearch.com/acute-kidney-injury-treatment-market-by-component-scheduling-524
About 700,000 deaths were linked to acute kidney failure in Europe, the United States and Japan. It is expected that a better understanding of acute kidney damage would increase the demand for treatment. Demand for urgent diagnosis of kidney injury raises the renal ultrasonography needed to check for the reversible source of acute kidney injury such as blocking of the kidney stones. Renal ultrasonography helps to identify acute ischemic injury to the kidney and to minimize blood flow in the renal network. Acute kidney failure has now been widely recognized as a serious health-care problem for several days. With a multifaceted quality assurance plan to improve care for acute kidney injury, the demand for medication is expected to grow. Acute kidney damage is increasingly prevalent in developed countries as well as developing ones. State awareness-raising initiatives are projected to promote healthcare industry growth through the introduction of various services relevant to Acute Kidney Injury. Acute Kidney Injury is expected to drive market growth by the medical or healthcare industry. Nevertheless, product side effects impede the market growth.
The market for Acute Kidney Injury Treatment is divided into injury type, therapy, distribution channel, and region. The injury type segment is classified into pre-renal, intrinsic renal and post-renal. In terms of injury form, the pre-renal acute kidney injury category had a major share in the global acute kidney injury care market in 2019. The group of pre-renal acute kidney injury is expected to gain market share in the acute kidney injury treatment industry by the end of 2026. The therapy segment is classified into Intermittent hemodialysis, Continuous renal replacement therapy, and Sustained low-efficiency dialysis. The therapy segment is classified into intermittent hemodialysis, continuous renal replacement therapy and sustained low-efficiency dialysis. The distribution channel segment is divided into Hospital Pharmacies, Online Pharmacies, and Others. In the coming years, the distribution channel community for hospital pharmacy will have a large portion. Medical stores usually stock a large number of medications and advanced equipment and provide care to hospital patients. The strain of genetic disorder will increase the number of hospitalizations and thus have a positive effect on medication production of hospitals.
Geographically the market is segmented into the regions that comprise the current and forecast market demand for the Asia Pacific, North America, Europe, Latin America, and Middle East & Africa with its further split into major countries. The rise in North America's disease-oriented drug research and the production of both accepted and symptomatic therapy for acute kidney injury was expected to dominate the global market for acute kidney injury care. Asia-Pacific, due to the large pool of patients and rising expenditure in better health care services, is projected to be the fastest-growing region for managing acute kidney injury.
Report Scope
Report Attribute |
Details |
Market Size in 2019 |
USD 1349.39 Million |
Projected Market Size in 2026 |
USD 2204.33 Million |
CAGR Growth Rate |
7.33% CAGR |
Base Year |
2019 |
Forecast Years |
2020-2026 |
Key Market Players |
AM-Pharma, Angion Biomedica Corp., Asahi Kasei Medical Co., Ltd., B. Braun Melsungen AG, Baxter International, Inc., Fresenius Medical Care AG & Co. KGaA, LG Chem, Quark Pharmaceuticals, Inc., and others. |
Key Segment |
By Injury Type, Therapy, Distribution Channel, and Region |
Major Regions Covered |
North America, Europe, Asia Pacific, Latin America, and the Middle East &, Africa |
Purchase Options |
Request customized purchase options to meet your research needs. Explore purchase options |
Some of the players included in the Acute Kidney Injury Treatment market are AM-Pharma, Angion Biomedica Corp., Asahi Kasei Medical Co., Ltd., B. Braun Melsungen AG, Baxter International, Inc., Fresenius Medical Care AG & Co. KGaA, LG Chem, Quark Pharmaceuticals, Inc. amongst others.
This report segments the Acute Kidney Injury Treatment market as follows:
Global Acute Kidney Injury Treatment Market: Injury Type Segment Analysis
- Pre-renal
- Intrinsic renal
- Post-renal
Global Acute Kidney Injury Treatment Market: Therapy Segment Analysis
- Intermittent hemodialysis
- Continuous renal replacement therapy
- Sustained low-efficiency dialysis
Global Acute Kidney Injury Treatment Market: Distribution Channel Segment Analysis
- Hospital pharmacies
- Online pharmacies
- Others
Global Acute Kidney Injury Treatment Market: Regional Segment Analysis
- North America
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- South Korea
- South-East Asia
- Rest of Asia Pacific
- Latin America
- Brazil
- Mexico
- Rest of Latin America
- The Middle-East and Africa
- GCC Countries
- South Africa
- Rest of Middle-East Africa
About Us:
Facts & Factors is a leading market research organization offering industry expertise and scrupulous consulting services to clients for their business development. The reports and services offered by Facts and Factors are used by prestigious academic institutions, start-ups, and companies globally to measure and understand the changing international and regional business backgrounds. Our client’s/customer’s conviction on our solutions and services has pushed us in delivering always the best. Our advanced research solutions have helped them in appropriate decision-making and guidance for strategies to expand their business.
Contact Us:
Facts & Factors
A - 2108, Sargam,
Nanded City,
Sinhagad Road,
Pune 411041, India
USA: +1-347-989-3985
Email: [email protected]
Web: https://www.fnfresearch.com
